Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-Cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice

Hepatology

Volumn 59, Issue 4, 2014, Pages 1351-1365

  Dolina, Joseph S ^a   Braciale, Thomas J ^a   Hahn, Young S ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ECALECTIN; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN; INTERLEUKIN 10; MUCIN 3; PROGRAMMED DEATH 1 LIGAND 1;

ADAPTIVE IMMUNITY; ADENOVIRUS INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SURFACE PROPERTY; TISSUE INJURY;

ADAPTIVE IMMUNITY; ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLULAR MICROENVIRONMENT; DISEASE MODELS, ANIMAL; GALECTINS; HMGB1 PROTEIN; IMMUNOGLOBULINS; LIVER; MICE; MICE, INBRED STRAINS; MUCIN-3; T-LYMPHOCYTES, REGULATORY;

EID: 84896491337     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26938     Document Type: Article

References (28)

1. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol.2009;27:147-163.
2. + T cells with dysfunctional anti-viral activity in the murine system. PLoS One 2009;4:e7619.
3. Callendret B, Walker C. A siege of hepatitis: immune boost for viral hepatitis. Nat Med 2011;17:252-253.
4. Tiegs G, Lohse AW. Immune tolerance: what is unique about the liver. J Autoimmun 2010;34:1-6.
5. Mills KHG. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 2004;4:841-855.
6. (+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000;192:303-310.
7. + responder cells by Fas-mediated apoptosis. J Immunol 2009;182:1469-1480.
8. + T regulatory cells express the Ly49 class I MHC receptor and are defective in autoimmune prone B6-Yaa mice. Proc Natl Acad Sci U S A 2011;108:2010-2015.
9. + T cell responses. J Immunol 2011;187:6301-6309.
10. + regulatory T-cell activity to suppress alloimmune responses. Transplantation 2007;83:774-782.
11. Blackburn SD, Wherry EJ. IL-10, T cell exhaustion and viral persistence. Trends Microbiol 2007;15:143-146.
12. Jin H-T, Anderson AC, Tan WG, West EE, Ha S-J, Araki K, et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A 2010;107:14733-14738.
13. Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol 2008;180:5771-5777.
14. Fife BT, Pauken KE, Eagar TN, Obu T, Wu J, Tang Q, et al. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat Immunol 2009;10:1185-1192.
15. + T cells. J Virol 2009;83:9122-9130.
16. Cao E, Zang X, Ramagopal UA, Mukhopadhaya A, Fedorov A, Fedorov E, et al. T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface. Immunity 2007;26:311-321.
17. Chiba S, Baghdadi M, Akiba H, Yoshiyama H, Kinoshita I, Dosaka-Akita H, et al. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol 2012;13:832-842.
18. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005;5:331-342.
19. Dumitriu IE, Baruah P, Valentinis B, Voll RE, Herrmann M, Nawroth PP, et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 2005;174:7506-7515.
20. Sundberg E, Fasth AER, Palmblad K, Harris HE, Andersson U. High mobility group box chromosomal protein 1 acts as a proliferation signal for activated T lymphocytes. Immunobiology 2009;214:303-309.
21. Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006;177:739-747.
22. Moorman JP, Wang JM, Zhang Y, Ji XJ, Ma CJ, Wu XY, et al. Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection. J Immunol 2012;189:755-766.
23. Rangachari M, Zhu C, Sakuishi K, Xiao S, Karman J, Chen A, et al. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion. Nat Med 2012;18:1394-1400.
24. Guy CS, Vignali KM, Temirov J, Bettini ML, Overacre AE, Smeltzer M, et al. Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. Nat Immunol 2013;14:262-270.
25. Rodriguez-Manzanet R, DeKruyff R, Kuchroo VK, Umetsu DT. The costimulatory role of TIM molecules. Immunol Rev 2009;229:259-270.
26. Klune J, Dhupar R. HMGB1: endogenous danger signaling. Mol Med 2008;14:1.
27. Kanzaki M, Wada J, Sugiyama K, Nakatsuka A, Teshigawara S, Murakami K, et al. Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes. Endocrinology 2012;153:612-620.
28. Jung JH, Park JH, Jee MH, Keum SJ, Cho MS, Yoon SK, et al. Hepatitis C virus infection is blocked by HMGB1 released from virus-infected cells. J Virol 2011;85:9359-9368.